Results 31 to 40 of about 13,238 (216)
The recent emergence of new variants of concern (VOCs) of SARS-CoV-2 and the uncertain duration of protection provided by the primary immunization cycle have highlighted the need for COVID-19 booster vaccinations.
Alborz Rahmani +14 more
doaj +1 more source
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review [PDF]
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus (COVID-19) outbreak a worldwide pandemic on March 11, 2020, due to its widespread infectivity pattern.
Swarnali Das +5 more
openaire +2 more sources
Diphtheria and tetanus vaccine: a comparative study of reactogenicity
One hundred and eighty children aged between four and six years were intensively followed-up after receiving diphtheria/tetanus vaccine. A daily diary was used as the method of assessment to elicit as many transient effects as possible. The results confirm the predicted profile of these vaccines with a high incidence of local effects but little general
K A, Bryett +3 more
openaire +2 more sources
Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England. [PDF]
Adults receiving heterologous COVID-19 immunisation with mRNA (Comirnaty) or adenoviral-vector (Vaxzevria) vaccines had higher reactogenicity rates and sought medical attention more often after two doses than homologous schedules.
Powell, AA +19 more
core +1 more source
In a previous study, we described a highly significant association between reactogenicity and SARS-CoV-2 RBD IgG titers and wild-type neutralization capacity in males after basic vaccination with BNT162b2.
Stilla Bauernfeind +9 more
doaj +1 more source
Stacked bar charts of maximum local and systemic reactogenicity over all vaccinations.
Local (A) and systemic (B) reactogenicity events. P values indicate differences between vaccine and placebo groups. Reactogenicity event grading color-code: red = life-threatening, orange = severe, pink = moderate, dark blue = mild, light blue = none.
Lynn Morris (7883) +30 more
core +1 more source
THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS [PDF]
. The article presents results of a prospective randomized study of reactogenicity, safety and immunogenicity of the polysaccharide pneumococcal vaccine “Pneumo 23” in the group of medical workers.
I. V. Feldblum +4 more
core +1 more source
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis [PDF]
There are limited data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine reactogenicity in persons with multiple sclerosis (PwMS) and how reactogenicity is affected by disease-modifying therapies (DMTs). The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis-specific vaccine safety ...
Farren Basil Shaw Briggs +13 more
openaire +2 more sources
Bivalent COVID-19 vaccines that contain BA.1 or BA.4/BA.5 have been introduced worldwide in response to pandemic waves of Omicron subvariants. This prospective cohort study was aimed to compare neutralizing antibodies (Nabs) against Omicron subvariants ...
Hak-Jun Hyun +13 more
doaj +1 more source
COMBINED VACCINES IN PEDIATRIC PRACTICE: WHEN THE PERTUSSIS VACCINE IS FUN!
Today the tendency towards reducing the invasive techniques in pediatric patients is of current importance. This also applies to vaccination. Creating a modern multi-vaccine reduces the number of painful injections to infants, because most of the ...
V. K. Tatochenko
doaj +1 more source

